Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TERN PLC Regulatory Filings 2023

Nov 24, 2023

7958_rns_2023-11-24_78797a36-ab83-483c-96c7-ac575debd7d2.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 5268U

Tern PLC

24 November 2023

REACH - non regulatory announcement

24 November 2023

Tern Plc

("Tern" or the "Company")

Investor Webinar Recording

Tern Plc (AIM:TERN), the company focused on value creation from Internet of Things ("IoT") technology businesses, announces that a recording of the investor webinar held on Tuesday 21 November 2023 and featuring presentations by Tern's portfolio companies Device Authority, Wyld Networks and Talking Medicines, together with a question and answer session, is available to view on the Company's website at: https://www.ternplc.com/resources

Enquiries

Tern Plc

Ian Ritchie (Chairman)
via IFC Advisory
Allenby Capital Limited

(Nominated Adviser and Broker)

Alex Brearley / Dan Dearden-Williams (Corporate Finance)

Kelly Gardiner / Guy McDougall (Sales and Corporate Broking)
Tel: 0203 328 5656
IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler
Tel: 0203 934 6630

[email protected]

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAFLFITLTLVFIV